In this issue:
- AI-supported mammography screening
- Breast cancer incidence in the era of mammography screening
- Exercise prescription in patients with breast cancer
- Radiation therapy management in BRCA1/2 carriers
- Axillary lymph node yield after neoadjuvant systemic therapy
- MRI-based personalisation of neoadjuvant chemotherapy duration
- Capecitabine versus paclitaxel after CDK4/6 inhibitor progression
- Imlunestrant with or without abemaciclib in advanced breast cancer
- Real-world TCHP neoadjuvant therapy in HER2+ breast cancer
- Palbociclib for HR+/HER2- advanced or metastatic breast cancer
Please login below to download this issue (PDF)